Health Care & Life Sciences » Pharmaceuticals | ALK-Abello A/S

ALK-Abello A/S

ALK-Abello A/S Series B
Stock Exchange Other OTC
EPS
 $1.5
Market Cap
 $2.41 B
Shares Outstanding
 9.21 M
Public Float
 -
ALK-Abello A/S Series B
Stock Exchange Copenhagen Stock Exchange
EPS
 DKK9.64
Market Cap
 DKK16.84 B
Shares Outstanding
 10.13 M
Public Float
 6.44 M

Profile

Address
Bøge Allé 6-8
Hørsholm CR 2970
Denmark
Employees -
Website http://www.alk.net
Updated 07/08/2019
ALK-Abello A/S engages in the production and development of pharmaceutical products to prevent and treat allergies. It also manufactures tablet-based allergy vaccines for pollen, house dust mites, animals, and insect stings. Its treatment comprises allergy vaccines, emergency treatment, and allergy diagnostics.

Financials

View All
Created with Highcharts 5.0.14ALK-Abello A/S Series BNet Income. Fiscal year is January-December. All values DKK Millions.61611811813443442702701581581701702013201420152016201720180100200300400
Created with Highcharts 5.0.14ALK-Abello A/S Series BSales/Revenue. Fiscal year is January-December. All values DKK Millions.2 2442 2442 4332 4332 5692 5693 0053 0052 9102 9102 9152 9152013201420152016201720180500100015002000250030003500

Jakob Riis
Director
Katja Barnkob Thalund
Director
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.